Eli Financial Statements From 2010 to 2025

LLY Stock  EUR 757.10  1.10  0.15%   
Eli Lilly financial statements provide useful quarterly and yearly information to potential Eli Lilly and investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Eli Lilly financial statements helps investors assess Eli Lilly's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Eli Lilly's valuation are summarized below:
Eli Lilly and does not presently have any fundamental signals for analysis.
Check Eli Lilly financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Eli Lilly's main balance sheet or income statement drivers, such as , as well as many indicators such as . Eli financial statements analysis is a perfect complement when working with Eli Lilly Valuation or Volatility modules.
  
This module can also supplement various Eli Lilly Technical models . Check out the analysis of Eli Lilly Correlation against competitors.

Eli Lilly and Company Price To Book Analysis

Eli Lilly's Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.

P/B

 = 

MV Per Share

BV Per Share

More About Price To Book | All Equity Analysis

Current Eli Lilly Price To Book

    
  35.00 X  
Most of Eli Lilly's fundamental indicators, such as Price To Book, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Eli Lilly and is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
Competition

Based on the latest financial disclosure, Eli Lilly and has a Price To Book of 35.0037 times. This is much higher than that of the Other sector and significantly higher than that of the Other industry. The price to book for all Germany stocks is notably lower than that of the firm.

Eli Lilly Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Eli Lilly's current stock value. Our valuation model uses many indicators to compare Eli Lilly value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Eli Lilly competition to find correlations between indicators driving Eli Lilly's intrinsic value. More Info.
Eli Lilly and is considered the number one company in current valuation category among its peers. It also is currently regarded as number one stock in price to book category among its peers . The ratio of Current Valuation to Price To Book for Eli Lilly and is about  9,637,842,175 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Eli Lilly's earnings, one of the primary drivers of an investment's value.

About Eli Lilly Financial Statements

Eli Lilly stakeholders use historical fundamental indicators, such as Eli Lilly's revenue or net income, to determine how well the company is positioned to perform in the future. Although Eli Lilly investors may analyze each financial statement separately, they are all interrelated. For example, changes in Eli Lilly's assets and liabilities are reflected in the revenues and expenses on Eli Lilly's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Eli Lilly and. Please read more on our technical analysis and fundamental analysis pages.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Information and Resources on Investing in Eli Stock

When determining whether Eli Lilly offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Eli Lilly's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Eli Lilly And Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Eli Lilly And Stock:
Check out the analysis of Eli Lilly Correlation against competitors.
You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Please note, there is a significant difference between Eli Lilly's value and its price as these two are different measures arrived at by different means. Investors typically determine if Eli Lilly is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Eli Lilly's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.